LHX vs MYGN · P/E 34, rev $5.88B vs rev $824.5M
L3Harris Technologies Inc (LHX) versus Myriad Genetics Inc (MYGN) — a side-by-side from cached financials, not a winner call.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
Myriad Genetics Inc (MYGN) is a diagnostics & research company listed on NASDAQ.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Latest reported MYGN revenue for 2025-12-31 was $824.5M. Net income was -$365.9M. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. MYGN currently screens at market cap $413.7M.
LHX currently screens at market cap $58.72B and trailing P/E 34.3. MYGN currently screens at market cap $413.7M.
Not investment advice. Open the LHX and MYGN stock pages for the full models.
Not investment advice.